50-MEGAVAR by Meditech Human Pharmaceuticals is a premium, high-potency oral anabolic compound featuring pure Oxandrolone (Anavar) at a dose of 50mg per tablet in a container/pack of 50 tablets. Engineered under strict pharmaceutical quality control standards, Meditech incorporates an anti-counterfeit verification system (scratch code check) on their packaging to guarantee exact chemical purity, correct dosing, and product authenticity.
Oxandrolone is a dihydrotestosterone (DHT)-derived anabolic steroid celebrated for its high anabolic activity paired with exceptionally low androgenicity. Unlike standard low-dosed Anavar formulations ($10\text{mg}$), 50-MEGAVAR provides a convenient, high-strength dose per tablet ($50\text{mg}$). It is widely utilized in contest preparation, cutting phases, and body re-composition cycles to promote clean lean muscle mass, enhance physical strength, and accelerate subcutaneous fat loss without water retention or aromatization.
Key Benefits & Applications
-
Zero Estrogenic Activity & No Fluid Retention: Does not convert to estrogen via the aromatase enzyme, guaranteeing zero subcutaneous water bloat, zero risk of gynecomastia, and a dry, hard, striated physical look.
-
Targeted Fat Loss & Metabolic Acceleration: Directly supports lipolysis (fat breakdown), particularly targeting visceral and subcutaneous abdominal fat while preserving hard-earned skeletal muscle tissue during calories-restricted cuts.
-
Significant Muscle Hardness & Density: Enhances nitrogen retention and cellular hydration within muscle tissue, promoting a dense, tight, and vascular appearance.
-
Impressive Strength Gains without Weight Gain: Significantly boosts intracellular Phosphocreatine (ATP) synthesis inside muscle tissue, yielding massive gains in raw strength and power without unwanted body weight additions.
-
High Anabolic Potential for Re-composition: Ideal for “recomp” phases where the user aims to simultaneously strip body fat and build lean, quality muscular tissue.






Reviews
There are no reviews yet.